- Home
- RIBB vs VNRX Comparison
RIBB vs VNRX Comparison
Compare RIBB & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIBB
- VNRX
- Stock Information
- Founded
- RIBB 2024
- VNRX N/A
- Country
- RIBB Japan
- VNRX United States
- Employees
- RIBB N/A
- VNRX N/A
- Industry
- RIBB
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RIBB
- VNRX Health Care
- Exchange
- RIBB NYSE
- VNRX Nasdaq
- Market Cap
- RIBB 64.9M
- VNRX 52.4M
- IPO Year
- RIBB 2025
- VNRX N/A
- Fundamental
- Price
- RIBB $10.15
- VNRX $0.66
- Analyst Decision
- RIBB
- VNRX Strong Buy
- Analyst Count
- RIBB 0
- VNRX 5
- Target Price
- RIBB N/A
- VNRX $3.88
- AVG Volume (30 Days)
- RIBB 11.8K
- VNRX 319.2K
- Earning Date
- RIBB 01-01-0001
- VNRX 08-13-2025
- Dividend Yield
- RIBB N/A
- VNRX N/A
- EPS Growth
- RIBB N/A
- VNRX N/A
- EPS
- RIBB N/A
- VNRX N/A
- Revenue
- RIBB N/A
- VNRX $1,308,361.00
- Revenue This Year
- RIBB N/A
- VNRX $563.72
- Revenue Next Year
- RIBB N/A
- VNRX $160.43
- P/E Ratio
- RIBB N/A
- VNRX N/A
- Revenue Growth
- RIBB N/A
- VNRX 64.16
- 52 Week Low
- RIBB $9.95
- VNRX $0.40
- 52 Week High
- RIBB $10.45
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- RIBB N/A
- VNRX 47.94
- Support Level
- RIBB N/A
- VNRX $0.62
- Resistance Level
- RIBB N/A
- VNRX $0.76
- Average True Range (ATR)
- RIBB 0.00
- VNRX 0.08
- MACD
- RIBB 0.00
- VNRX -0.02
- Stochastic Oscillator
- RIBB 0.00
- VNRX 12.47
About RIBB RIBBON ACQUISITION CORP
Ribbon Acquisition Corp is a blank check company.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.